Home / Pharmaceutical company intelligence
Standpharm Pakistan Pvt Ltd logo
Pharmaceutical company intelligence

Standpharm Pakistan products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Private pharmaceutical manufacturer · Lahore · Pakistan

Lahore-based pharmaceutical manufacturer with branded medicinal products and manufacturing operations on Ferozepur Road.

Standpharm Pakistan products in Pakistan

Standpharm Pakistan Pvt Ltd has 143 medicine presentations registered in Pakistan under 50 brands, covering 48 generic medicines. Most of its products are in Anti-infectives, CNS & mental health and Pain & musculoskeletal. Its brands with the most registered strengths and packs are Livorip (Ribavirin), Bludol (Ibuprofen), Levra (Levetiracetam) and Neon (Ceftriaxone). 143 products have an official DRAP price on MedInfoBase. See all 50 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation13 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check12 Oct 2026Latest source-check date across this published portfolio
Latest effective price date28 Sep 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
STANDPHARM Pakistan (Pvt) Ltd.
Company type
Private pharmaceutical manufacturer
Address
20-KM, Ferozepur Road, Lahore, Pakistan
Phone
+92 42 35953305; +92 42 35953308
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000051 Standpharm Pakistan (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000051 145 linked products · source seen 13 Nov 2026 View source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx153public portfolio records represented
REG126unique registrations represented
IDX9indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER84registry-verified exact registrations
PKR143current validated price records
G48generic molecules in indexed catalogue
DF8dosage-form groups
TA11therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage93%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage97%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixStandpharm Pakistan Pvt LtdShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/standpharm-pakistan-pvt-ltdGenerated 13 Nov 2026Anti-infectives75 · 52%CNS & mental health18 · 13%Pain & musculoskeletal11 · 8%Gastrointestinal & hepatology10 · 7%Vitamins, minerals & nutrition9 · 6%Cardiovascular8 · 6%Endocrine & metabolic3 · 2%Other therapeutic areas9 · 6%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioStandpharm Pakistan Pvt LtdDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/standpharm-pakistan-pvt-ltdGenerated 13 Nov 2026143presentationsTablet79 · 55%Injection26 · 18%Suspension15 · 10%Capsule10 · 7%Drops4 · 3%Infusion4 · 3%Other forms5 · 3%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionStandpharm Pakistan Pvt LtdCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/standpharm-pakistan-pvt-ltdGenerated 13 Nov 2026138comparable productsBelow peer median31 · 22%Near peer median63 · 46%Above peer median44 · 32%Company median price position-1.7%Lowest-price equivalents1Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsStandpharm Pakistan Pvt LtdCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/standpharm-pakistan-pvt-ltdGenerated 13 Nov 2026HIGH-Q Pharmaceuticals34 shared71% overlapNabiqasim Industries (Pvt) Ltd.,32 shared67% overlapZafa Pharmaceutical Laboratories (P…32 shared67% overlapMediate Pharmaceutical Pvt Ltd32 shared67% overlapNeutro Pharma (Pvt.) Ltd.,32 shared67% overlapShaigan Pharmaceuticals (Pvt) Ltd31 shared65% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Formulation footprint

Dosage forms

Tablet79 products
Injection26 products
Suspension15 products
Capsule10 products
Drops4 products
Infusion4 products
Syrup3 products
Solution2 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where Standpharm Pakistan Pvt Ltd is priced against the market

138 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers116Distinct registrations among indexed, published, presentation-validated products only
Verified price observations185
Products with a verified price143
Products with multiple price observations21
Source records with multiple versions143
Latest portfolio source check12 Oct 2026
Latest effective price date28 Sep 2026
Latest source observation13 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

126 unique registration(s) · 9 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Anemix Iron polymaltose complex 50 mg/mL Oral drops 30ml 049067 PKR 228.97 PKR 7.63/mL 🔒 Pharma Pro
Anemix Iron polymaltose complex 50 mg/mL Oral drops 15ml 049067 PKR 120.02 PKR 8.00/mL 🔒 Pharma Pro
Anemix Iron polymaltose complex 50 mg/5 mL Syrup 60ml 049068 PKR 129.27 PKR 2.15/mL 🔒 Pharma Pro
Anemix Iron polymaltose complex 100 mg Tablet 2x10's 053679 PKR 313.93 PKR 15.70/tablet 🔒 Pharma Pro
Ceevit Ascorbic acid 500 mg Chewable tablet 40's 106034 PKR 53.06 PKR 1.33/tablet 🔒 Pharma Pro
Maltron Iron polymaltose complex + Folic acid 100 mg elemental iron + 0.35 mg folic acid Chewable tablet 10's 053678 PKR 129.27 PKR 12.93/tablet 🔒 Pharma Pro
Sanjuis Ferrous sulfate 350 mg Tablet 20's 020282 PKR 84.32 PKR 4.22/tablet No comparator
Tri-D Cholecalciferol 5 mg Injection 1mlx5's 083856 PKR 862.35 PKR 172.47/mL 🔒 Pharma Pro
Tri-D Cholecalciferol 5 mg Injection 1mlx1's 083856 PKR 171.74 PKR 171.74/mL 🔒 Pharma Pro
A to Z

All 50 Standpharm Pakistan brands in Pakistan

  • A-Mal Artemether · 20 mg tablet, 40 mg tablet, 80 mg tablet
  • Anemix Iron polymaltose complex · 100 mg tablet, 50 mg/5 mL syrup, 50 mg/mL drops
  • Angipin Amlodipine · 10 mg tablet, 5 mg tablet
  • Bacnil Amoxicillin + clavulanic acid · 250 mg + 125 mg tablet
  • Bludol Ibuprofen · 100 mg/5 mL suspension, 200 mg tablet, 200 mg/5 mL suspension
  • Ceevit Ascorbic acid · 500 mg tablet
  • Cefix Cefixime · 100 mg/5 mL suspension, 200 mg capsule, 200 mg/5 mL suspension
  • Cisec Omeprazole · 20 mg capsule, 40 mg injection, 40 mg capsule
  • Femiclo Clomifene citrate · 50 mg tablet
  • Furitax Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
  • Husquin Hydroxychloroquine · 200 mg tablet
  • Kolex Simvastatin · 10 mg tablet, 20 mg tablet, 40 mg tablet
  • Lactosole Lactulose · 10 g/15 mL syrup
  • Larex Albendazole · 200 mg tablet
  • Levra Levetiracetam · 100 mg/mL solution, 1000 mg tablet, 250 mg tablet
  • Lith SR Lithium carbonate · 400 mg tablet
  • Livorip Ribavirin · 400 mg tablet, 500 mg tablet, 600 mg tablet
  • Lomogin Lamotrigine = · 100 mg tablet, 25 mg tablet, 50 mg tablet
  • Lorel Loratadine · 10 mg tablet, 5 mg/5 mL syrup
  • Maltron Iron polymaltose complex + Folic acid · 100 mg elemental iron + 0.35 mg folic acid tablet
  • Mephage Metformin · 500 mg tablet
  • Monocor Bisoprolol fumarate · 10 mg tablet, 2.5 mg tablet, 5 mg tablet
  • Moxime Cefuroxime · 250 mg injection, 750 mg injection
  • Neon Ceftriaxone · 1 g injection, 2 g injection, 250 mg injection
  • Nodibet Gliclazide · 80 mg tablet
  • Nodibet SR Gliclazide · 30 mg tablet
  • Orsidon Risperidone · 1 mg tablet, 2 mg tablet, 3 mg tablet
  • Paracet Paracetamol · 500 mg tablet, 80 mg/0.8 mL drops
  • Protoxil Metronidazole · 200 mg tablet, 200 mg/5 mL suspension, 400 mg tablet
  • Ranax Ranitidine · 150 mg tablet, 300 mg tablet, 50 mg/2 mL injection
  • Resque Azithromycin · 200 mg/5 mL suspension, 500 mg tablet
  • Resque Capules Azithromycin · 250 mg capsule
  • Riomed Clarithromycin · 125 mg/5 mL drops, 125 mg/5 mL suspension, 250 mg tablet
  • Sandem Ondansetron · 8 mg tablet, 8 mg/4 mL injection
  • Sanjuis Ferrous sulfate · 350 mg tablet
  • Seltium Oseltamivir · 75 mg capsule
  • Stan-Q Chloroquine · 250 mg tablet
  • Stanflox Levofloxacin · 250 mg tablet, 500 mg tablet
  • Staxin Moxifloxacin · 400 mg tablet
  • T-Mus Tacrolimus · 0.5 mg capsule, 1 mg capsule, 5 mg capsule
  • Thrombonil Clopidogrel · 150 mg tablet, 75 mg tablet
  • Tizid Ceftazidime · 1 g injection, 250 mg injection, 500 mg injection
  • Tri-D Cholecalciferol · 5 mg injection
  • Viloc Ciprofloxacin · 100 mg/50 mL infusion, 125 mg/5 mL suspension, 250 mg tablet
  • Virolem Lamivudine · 100 mg tablet
  • Vitaclox Ampicillin + Cloxacillin · 125 mg + 125 mg injection
  • Vonder Fluoxetine · 20 mg capsule
  • Zeclon Sulfasalazine · 500 mg tablet
  • Zolistat Linezolid · 600 mg tablet, 600 mg/300 mL infusion
  • Zomacin Amikacin · 100 mg injection, 250 mg injection, 500 mg injection
Questions

Standpharm Pakistan: common questions

How many products does Standpharm Pakistan have in Pakistan?

Standpharm Pakistan Pvt Ltd has 143 registered medicine presentations in Pakistan, sold under 50 brands and covering 48 generic medicines.

What are the main brands of Standpharm Pakistan?

By number of registered strengths and packs, its largest brands are Livorip (Ribavirin), Bludol (Ibuprofen), Levra (Levetiracetam), Neon (Ceftriaxone) and Viloc (Ciprofloxacin). This is not a sales ranking.

Which therapy areas does Standpharm Pakistan cover?

The most products are in Anti-infectives (75), CNS & mental health (18), Pain & musculoskeletal (11), Gastrointestinal & hepatology (10) and Vitamins, minerals & nutrition (9).

Where can I see Standpharm Pakistan medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Standpharm Pakistan Pvt Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 13, 2026, from https://medinfobase.com/company/standpharm-pakistan-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9